Authors Posts by Head Editor

Head Editor


0 459

Zoned Properties Eliminates Current Debt, Retires $1 Million of Convertible Notes

“Retiring and replacing higher cost debt with longer-term financing at an attractive cost of capital lowers our quarterly costs of debt service and puts in place a capital structure that better supports our ongoing property development projects for the long-term,” commented Bryan McLaren, Chief Executive Officer of Zoned Properties. “As a result of the private placement and sale of one of our Tempe properties, we have lowered our cost of unsecured debt by 100 basis points and extended maturities. 100% of our total debt outstanding now matures in 2022.”

Under the terms of a private placement transaction, in January 2017, the Company issued $2.02 million in five-year convertible notes paying quarterly interest at the rate of 6.0% per annum. A portion of the net proceeds of $1.06 million, excluding transaction costs and other related expenses, was used to repay the Company’s two convertible notes issued in August 2014 for $1 million, in aggregate, and accrued interest of approximately $96,000. The newly placed 2017 convertible notes may be converted at the holder’s option at a conversion price of $5.00 per share.

The 2014 convertible notes, which bore an interest rate of 7% per annum and provided a conversion feature to the Company’s common stock at $5.00 per share, were scheduled to mature in August 2017.

About Zoned Properties, Inc. (ZDPY):

Zoned Properties is a strategic real estate development firm whose primary mission is to identify, develop, and lease sophisticated, safe, and sustainable properties in emerging industries, including the licensed medical marijuana industry. The Company acquires commercial properties that face unique zoning challenges and identifies solutions that can potentially have a major impact on the cash flow and property value. Zoned Properties targets commercial properties that can be acquired and re-zoned for specific purposes. Zoned Properties does not grow, harvest, sell or distribute cannabis or any substances regulated under United States law such as the Controlled Substances Act.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believe,” “expect,” “anticipate,” “plan,” “potential,” “continue” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks and uncertainties are discussed in the Company’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company’s control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

0 614

Terra Tech Corp. CEO, Derek Peterson, Discusses Recent News and Provides an Outlook for the Company in a New Audio Interview at, Inc. (SCV) and Terra Tech Corp. (OTC QX:TRTC) (“Terra Tech”) or (the “Company”), a vertically integrated cannabis-focused agriculture company, announced today that a new audio interview with the Company is now available. The interview can be heard at

Derek Peterson, CEO of Terra Tech, called in to to go over the exciting news for Terra Tech Corp. Topics covered in the interview include the recent White House comments on the cannabis industry, market penetration in California, the overwhelming successes in Nevada, the steady growth for Edible Gardens and more.

In the interview, regarding the current administration’s stance on cannabis, Peterson stated, “If we were having this conversation two years ago it wouldn’t be what it is today, but last November we had eight of the nine pieces of national legislation go through. That shows overwhelming support for an expanded regulatory environment for cannabis even in swing states. If there’s one thing this administration has built their platform around, it’s state’s rights.”

Speaking about the Nevada markets, Peterson went on to say, “What we went after was eight permits thinking we would be thrilled to get two and we got all eight. Today, we have four operational retail dispensaries spread throughout the Las Vegas area as well as Reno. We are building two large scale cultivation and extraction facilities to meet the wholesale demand for the IVXX brand.”

About Terra Tech

Terra Tech Corp. (OTC QX:TRTC) operates through multiple subsidiary businesses including: Blüm, IVXX Inc., Edible Garden, MediFarm LLC and GrowOp Technology.  Blüm’s retail medical cannabis facilities focus on providing the highest quality medical cannabis to patients who are looking for alternative treatments for their chronic medical conditions. Blüm offers a broad selection of medical cannabis products including; flowers, concentrates and edibles through its Oakland, CA and multiple Nevada locations. IVXX, Inc. is a wholly-owned subsidiary of Terra Tech that produces medical cannabis-extracted products for regulated medical cannabis dispensaries throughout California. The Company’s wholly-owned subsidiary Edible Garden cultivates a premier brand of local and sustainably grown hydroponic produce, sold through major grocery stores such as ShopRite, Walmart, Winn-Dixie, Raley’s, Meijer, Kroger, and others throughout New Jersey, New York, Delaware, Maryland, Connecticut, Pennsylvania and the Midwest. Terra Tech’s MediFarm LLC subsidiaries are focused on medical cannabis cultivation and permitting businesses throughout Nevada. The Company’s wholly-owned subsidiary GrowOp Technology specializes in controlled environment agricultural technologies.

To be added to the Terra Tech email distribution list, please email with TRTC in the subject line.

For more information about Terra Tech Corp. visit:
For more information about IVXX visit:
For more information about Blüm Nevada visit:
For more information about Blüm Oakland visit:
Visit us on Facebook @
Follow us on Twitter @terratechcorp
Follow us on Instagram @ivxxelevate420
For more information about Edible Garden visit:
Visit Edible Garden on Facebook @
Visit IVXX on Facebook @

About is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about and their services, please visit

0 1881

Vitality Biopharma Releases Clinical Report of Cannabinoid Therapy for Pediatric IBD

The report is a case study titled, “Induction of Remission in Drug-Resistant Pediatric Inflammatory Bowel Disease with Cannabinoid Therapy,” and describes a 13-year-old boy with drug-resistant Crohn’s disease and colitis who achieved clinical remission after oral administration of cannabinoids. Independently from the Company, the patient received treatment with medical cannabis pursuant to the State of California’s Compassionate Use Act. The case study describes how the patient’s disease could not be controlled by currently-approved pharmaceuticals, and how cannabinoid treatment led to near-immediate clinical improvement that was indicative of disease remission. The report by Vitality Biopharma and its collaborators is a preprint scientific manuscript that has not yet been subjected to peer review, and additional case reports may be included prior to formal publication. The full report can be accessed here:

Clinical trials in IBD patients have previously shown that use of cannabis is associated with substantial symptomatic relief, and placebo-controlled trials have confirmed significant declines in disease activity score after treatment. However, these trials largely relied on subjective outcome measures. The case study detailed by Vitality Biopharma and its collaborators is one of the first where multiple objective measures of disease outcome were reported. This included analysis of fecal calprotectin levels, which increase when lesions or tears in the intestinal tract are present, and decrease when healing of the gut mucosal lining occurs. The case study results provide objective evidence that cannabinoids may not only resolve symptoms of IBD, but also modify disease through reduction of gut inflammation.

About Vitality Biopharma ( OTCQB : VBIO )
Vitality Biopharma is dedicated to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. For more information, visit: Follow us on Facebook, Twitter and LinkedIn.

Notice Regarding Forward-Looking Statements
This news release contains “forward-looking statements” as that term is defined in Section 27(a) of the United States Securities Act of 1933, as amended and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

0 807

HempLife Today Celebrates 420 and Rewards Its Growing Customer Base With its Biggest Sale of the Year

Company offers 30% off on all products this weekend

This special 420 sale starts today, 4.20.2017, and will continue until Monday the 24th at Midnight Eastern. Throughout this period all current HempLife Today™ customers, and everyone in the general public, can get 30% off of any size order of CannazALL™ CBD products, and all products are ready to ship within 24 hours via the Companies Rapid Ship processing system.

The Company wants everyone to know that they can get this 30% discount on all CannazALL™ products; Tinctues, Concentrates, GelCaps, and Vape products, by clicking the link or visiting, using Coupon Code Save420.

CEO James Ballas said, “We are off to a great year in 2017, and want to offer the biggest savings that we can to honor our customers. We only do a 30% discount twice a year, 420 and the Holidays, so this is a very special opportunity to stock up on all the popular CannazALL products. We also look forward to the new customers who can take advantage and encourage everyone to share this sale with as many others as possible.”

*The Company is also working on a shareholder update covering all aspects of the business, planned for release next week.

About HempLife Today™

Hemp Life Today™ was created by a group of highly motivated, skilled and health minded people. Who have learned that Hemp, and Hemp related products, can be a great source of increased health, vitality, and overall well being in our lives. We also believe that high grade CBD (Cannabidiol), could very well be the miracle supplement the world has been waiting for as more and more people discover the health benefits of this remarkable extract. HempLife Today™ offers its quality CBD products @

About Ubiquitech

Ubiquitech Software Corp, through its subsidiaries is a dynamic multi-media, multi-faceted corporation utilizing state-of-the-art global internet marketing, Direct Response (DRTV) Television, Radio, and traditional marketing, to drive traffic to the new and emerging multi-billion dollar industries like its subsidiary HempLifeToday™.

HempLifeToday™ focuses on the exciting and dynamic new thinking in the world today that recognizes the important health and life enriching enhancement that CBD Oil from the Hemp plant can bring. Through its network of quality USA growers™ has developed multiple and proprietary CannazALL™ CBD oil products that include its popular CBD Tinctures, Oils, GelCaps, CBD Powder, Skin Salve, Wax Honey, and e-liquid, all offered @

This press release contains forward-looking statements. Words such as “expects”, “intends”, “believes”, and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, the ability to secure additional sources of finance, the ability to reduce operating expenses, and other factors described in the Company’s filings with the OTC Markets Group. The actual results that the Company achieves may differ materially from any forward-looking statement due to such risks and uncertainties. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

0 222

Green cures & Botanical Distribution Inc. (OTC PINK: GRCU) Celebrates 420 Day With Hollywood Hemp(TM) Product Line on

 To join the world in the Global Celebration of 420, Green Cures and Botanical Distribution Inc. ( OTC PINK : GRCU ) is issuing an invitation to be a part of enjoyment of its proprietary Hollywood Hemp™ revolutionary product line on

This innovative line still includes the following products: Original Hollywood Hemp™ Sugar Scrub, Relaxing Hollywood Hemp™ 7-Piece Bath & Body Soap Gift Set, Original Hollywood Hemp™ Natural Lotion Bar, Original Hollywood Hemp™ Natural Lip Balm and Original Hollywood Hemp™ Glycerin Bar Soap. Utilizing any of these all-natural hemp based products will introduce your skin to the proven antioxidant features of hemp while doing your part in cutting down carcinogens released into Earth’s atmosphere during the production of unnatural beauty products.

GRCU will continue to expand their hemp category by continuing to partner with innovative leaders in the hemp sector. All of the GRCU all-natural Hollywood Hemp™ product line can be found at the upcoming groundbreaking event “Hemp-Con” in San Bernardino. “Join the world and celebrate with GRCU on April 20th. Savor the luxurious beauty benefits and the numerous health benefits of hemp by indulging yourself this holiday,” invites Michael Lajtay (Pronounced “Lay-tay”) Chief Operating Officer of GRCU.

Look forward to the upcoming GRCU Hemp and CBD Infused Coffee as well as other exciting products in the next quarter.

About Green Cures& Botanical Distribution, Inc. (OTC PINK: GRCU)
Green Cures & Botanical Distribution Inc., is revenue-generating company that wholesales and retails hemp-infused nutritional, botanical, sports, and body care products. The company is currently Web-based and focuses on online retailing. Green Cures & Botanical Distribution Inc., operates a diverse portfolio of products and services within the botanical and cannabis industry, as permitted by law. From concept to production and distribution, Green Cures & Botanical Distribution Inc., is continuously creating and introducing products that promote a healthy life style. For more information visit:

Forward-Looking Statements Disclaimer:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are contained in the Edgar Archives of the Securities and Exchange Commission at

0 306

MassRoots Partners with Whoopi & Maya as Part of Multi-State Expansion Strategy

MassRoots, Inc. (MSRT), a leading technology platform for medical cannabis patients and businesses, is pleased to announce it has partnered with Whoopi & Maya, a medical cannabis product company founded by Whoopi Goldberg and Maya Elisabeth, to promote their expansion plans, which are expected in the coming months.

“We are thrilled with the reception Whoopi & Maya has gotten in our first year in California and women have been reaching out to us from all over asking when they’ll be able to get their hands on them, too,” stated Whoopi Goldberg, co-founder of Whoopi & Maya. “We’re excited to be working with an industry leader like MassRoots to get the word out and help more women find relief from pain and menstrual discomfort.”

“Whoopi & Maya represents the next generation of cannabis products – focused on quality and geared towards mainstream consumers,” stated MassRoots CEO Isaac Dietrich. “We’re excited to welcome them to the one million-user strong MassRoots community and help expand their market share in the rapidly growing medical cannabis industry.”

About Whoopi & Maya
Whoopi & Maya was launched in 2016 by Whoopi Goldberg and award-winning edibles maker Maya Elisabeth, founder of Om Edibles and winner of nine High Times Cannabis Cup awards.  The California-based medical marijuana company’s initial offerings included a signature line of herbal medical cannabis products, formulated to provide relief for women experiencing menstrual cramps and discomfort, including Raw sipping chocolate, THC-infused tincture, THC-infused bath soak and topical rub for localized pain.  One year later, Whoopi & Maya products are available in over 300 dispensaries, becoming one of the fastest growing brands in California, with plans to announce line extensions and regional expansions shortly.  Learn more at

About MassRoots
MassRoots is one of the largest technology platforms for the regulated cannabis industry. The Company’s mobile apps enable consumers to make educated cannabis purchasing decisions through community-driven reviews. MassRoots is proud to be affiliated with the leading businesses and organizations in the cannabis industry, including the ArcView Group and National Cannabis Industry Association. For more information, please visit

Forward-looking Statements
Certain matters discussed in this announcement contain statements, estimates and projections about the growth of MassRoots’ business, potential partnerships, new features, and related business strategy. Such statements, estimates and projections may constitute forward-looking statements within the meaning of the federal securities laws. Factors or events that could cause our actual results to differ may emerge from time to time. MassRoots undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The recipient of this information is cautioned not to place undue reliance on forward-looking statements.

To view the original version on PR Newswire, visit:–maya-as-part-of-multi-state-expansion-strategy-300442608.html

0 172

New Frontier Data & MassRoots Partner on First Cannabis Consumer Sentiment Report

“We have been looking at consumer sentiment in various forms from our own national survey to our ingestion of social media data from multiple platforms. Over the past two years New Frontier Data has been working diligently to understand evolving attitudes, perceptions and use of cannabis. This partnership will allow us to take that research one step further and provide the industry with a deeper understanding of this vastly complex market,” said Giadha Aguirre De Carcer.

“Over the past three years, we’ve built a community of over a million of the world’s most passionate cannabis consumers. In conjunction with New Frontier Data, we’re releasing the first cannabis consumer sentiment report, which will analyze the hundreds of millions of anonymized data points surrounding cannabis purchasing decisions,” stated MassRoots Chief Executive Officer Isaac Dietrich. “This information is invaluable to businesses and brands looking to market to the tens of millions of cannabis consumers in the United States and abroad.”

Our executive team possesses the skill, experience, and knowledge necessary to analyze the depth of data that MassRoots can provide us. New Frontier Data recently poached a pioneer and veteran of the technology sector. Prior to joining as Chief Operating Officer, Gary Allen began his career in the mid 90s pioneering mobile banking with ABN-AMRO, then went on to multiple ad tech successes from affiliate marketing to market leading search technology with Performics and DoubleClick.

“The combination of the industry analytics and reporting from New Frontier Data and the consumer understanding the cannabis social giant MassRoots provides us interesting technology analysis and engagement opportunities. As the cannabis industry continues to mature leading technologies such as the MassRoots social application and New Frontier Data’s Equio platform will provide investors, consumers, operators, and marketers exciting opportunities to connect and understand each other,” said Gary Allen, New Frontier Data COO.

The collective data, analytics, and reach of the New Frontier Data and MassRoots team provide a unique insight into the purchasing patterns of loyal cannabis consumers.

About New Frontier Data:
New Frontier Data is an independent, technology-driven analytics company specializing in the cannabis industry. We offer vetted data, business intelligence and risk management solutions for investors, operators and policymakers. New Frontier’s data and reports have been cited in over 45 countries around the world to inform industry leaders. Founded in 2014, New Frontier is headquartered in Washington, D.C. and an additional office in Denver. For more information or media inquiries, please visit or contact Gretchen Gailey at 202-489-3821 or

About MassRoots, Inc.
MassRoots is one of the largest technology platforms for the regulated cannabis industry. The Company’s mobile apps enable consumers to make educated cannabis purchasing decisions through community-driven reviews. MassRoots is proud to be affiliated with the leading businesses and organizations in the cannabis industry, including the ArcView Group and National Cannabis Industry Association. For more information, please visit

0 850
VPR Brands

VPR Brands launches alongside its onsite retail store

“Our new website mall is a natural extension of our product offering which will catalog and offer for sale all of our brands along with the top selling brands in the industry across all categories from vape to smoke and more. In addition to shipping from our warehouse, we have supplier relationships with the largest distributors in South Florida as well as across the nation to drop ship orders directly from their warehouses and out of their stock in order for us to capitalize on their inventory thereby saving time and money,” says Kevin Frija CEO of VPR Brands LP.

“Our team has put together a great assortment of products offered in our brick and mortar store, from an amazing selection of vape products to the best in glass and smoking accessories. The launch of our new website will be a great one-stop shop for many customers as well as resellers in an easy to navigate, user-friendly environment. will be a well-diversified online storefront and updated often with the latest and greatest products,” says Dan Hoff COO.

About VPR Brands, LP:
VPR Brands is a technology company, whose assets include issued U.S. and Chinese patents for atomization related products including technology for medical marijuana vaporizers and electronic cigarette products and components. The company is also engaged in product development for the vapor or vaping market, including e-liquids. Vaporizers and electronic cigarettes (also known as e-cigarettes) are devices which deliver nicotine and or cannabis through atomization or vaping, and without smoke and other chemical constituents typically found in traditional products. For more information about VPR Brands, please visit the company on the web at

Forward-looking statements:
This news release contains statements that involve expectations, plans or intentions, and other factors discussed from time to time in the company’s Securities and Exchange Commission filings. These statements are forward-looking and are subject to risks and uncertainties, so actual results may vary materially. The company cautions readers not to place undue reliance on any forward-looking statements, which speak only as of the date made. The company disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

0 1406

Medical marijuana will be grown on up to 24 licensed sites statewide, subject to some of the highest fees in the country, under the final rules recently presented to legislators. The cultivator portion of the rules, which also details the application and license fees for retail dispensaries, product processors and testing labs, cleared the Ohio legislature’s Joint Committee on Agency Rule Review without objection from the panel.

The rules will be officially filed later this month and take effect before the May 6th statutory deadline. Rules and regulations for retail dispensaries, product processors and testing labs are still being revised, but must be in place by September 8th. Columbus attorney David Patton raised concerns about banning license applicants with criminal records. Ohio law allows people convicted of certain crimes, to be determined by regulators, to be eligible for marijuana business licenses if the offenses occurred more than five years prior.

Patton said the rules don’t set a hard line between which offenses qualify or disqualify someone and the state is setting itself up for a lawsuit. Under the rules, a first-degree misdemeanor conviction or guilty plea doesn’t “automatically disqualify” someone to obtain a license or work as a key dispensary employee if it occurred more than five years ago. Possessing more than 200 grams of marijuana, or a little over 7 ounces, is a felony charge in Ohio.

Patton recently said, “Nobody wants criminals involved in the medical marijuana program, but the fact is most of the people who understand this industry have been engaged in medical marijuana activities and recreational activities for decades.” Justin Hunt, chief operating officer for the Ohio Medical Marijuana Control Program, said the pertinent offenses are clearly listed in the rules.

Hunt stated, “The authority we have is broad to draft the rules; that help us establish a safe medical marijuana program and ensure a safe, consistent supply for the patients that will ultimately rely on this medicine.” Ohio’s medical marijuana law, passed in June 2016, allows people with one of 21 medical conditions to buy and use marijuana if recommended by a physician. Most of the details about the program, such as who will grow and sell marijuana and how much patients can buy, were left to the commerce department, Ohio State Board of Pharmacy and Ohio State Medical Board.

The Department of Commerce plans to begin accepting applications for cultivator licenses in June, after a few weeks of answering questions from interested parties. Applicants must meet certain financial criteria, have local approval for their proposed site and submit security and quality assurance plans, among other requirements. The rules and regulations have not substantially changed in the five months since first proposed by the department, despite concerns about the pricey license fees and out-of-state investors having an advantage over Ohioans.

0 1265

Americans think it’s safer to use marijuana than opioids to relieve pain, but they were less comfortable with children and pregnant women using the drug to treat medical conditions, according to a recent Yahoo/Marist poll. Two-thirds of the respondents in the telephone survey said opioid drugs such as Vicodin or OxyContin are “riskier” to use than marijuana, even when the pain pills are prescribed by a doctor. Only one in five said marijuana was riskier than opioids. The rest weren’t sure.

Every day, an overdose of prescription opioids or heroin kills 91 people, and legions more are brought back from the brink of death. Some 2 million Americans are thought to be hooked on the pills. Last month, President Donald J. Trump appointed an opioid commission to look into the problem. Marijuana by itself is not fatal. Doctors technically don’t prescribe it for pain or other purposes but most states that allow medical marijuana do require patients to get a doctor’s written recommendation to purchase it to treat their conditions.

Among those answering the Yahoo/Marist poll, 83% said the drug should be legal nationally for medical treatment. However, 70% said it is not acceptable for pregnant women to use marijuana to reduce nausea or pain. And the survey respondents were about evenly divided on whether marijuana should be recommended for children if it were legal. The survey respondents were deeply divided on how Trump should approach marijuana: 38% said he shouldn’t be as tough about enforcing federal laws against recreational marijuana use as President Barack Obama, whose policy generally was to leave states alone.

Another 30% said Trump should take a harder line than Obama, while the rest weren’t sure or said Trump should treat it about the same as Obama did. Trump’s administration has sent mixed messages to the 28 states and Washington, D.C., in violation of federal drug law when it comes to marijuana. Trump said as a candidate that states should be allowed to tinker with marijuana laws. However, new U.S. Attorney General Jeff Sessions has said marijuana is dangerous and marijuana changes by states should not be allowed. There has been no action yet by the U.S. Justice Department or any other federal agencies to crack down on states violating the Controlled Substances Act, which bans marijuana for any use.

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact
Ad Placements